Immune Thrombocytopenia epidemiology and demographics

The incidence of Immune thrombocytopenia is approximately 1.6- 3.9 per 100,000 adult individuals worldwide and 1.1- 5.8 per 100,000 individuals among children. Patients of all age groups may develop Immune thrombocytopenia. The Prevalence of chronic Immune thrombocytopenia increases with age. Black and non-hispanic individuals are less likely to develop ITP.

• The incidence of Immune thrombocytopenia is approximately 1.6- 3.9 per 100,000 adult individuals worldwide and 1.1- 5.8 per 100,000 individuals among children. The overall incidence rate was higher in women (4.4 per 100,000 person year) than men ( 3.4 per 100,000 person year).Women are more commonly affected by Immune thrombocytopenia than men.
• In year 2014, the incidence of Immune thrombocytopenia among French people is approximately 2.9/ 100,000 person years with higher incidence among women. The incidence has bimodal distribution with first peak among male children among 1-5 years and men over 75 years of age. However the distribution for women is constant.^{[1] [2]}

• The prevalence of chronic immune thrombocytopenia ( lasting longer than 12 months) is approximately 9.5-11.2 per 100,000 individuals in the United States.
• In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
• The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

• In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
• The case-fatality rate/mortality rate of [disease name] is approximately [number range].

• Patients of all age groups may develop Immune thrombocytopenia.
• The Prevalence of chronic Immune thrombocytopenia increases with age; the childhood ITP remits spontaneously.
• Immune thrombocytopenia commonly affects individuals younger than 5 years of age.
• [Chronic disease name] is usually first diagnosed among [age group].
• [Acute disease name] commonly affects [age group].

• There is no racial predilection to [disease name].
• Black and non-hispanic individuals are less likely to develop ITP, thereafter, the providers should suspect alternative diagnosis or secondary ITP in these races.^[3]

• [Disease name] affects men and women equally.
• Women are more commonly affected by Immune thrombocytopenia than men.

• The majority of Immune thrombocytopenia cases are reported in January and the minority in summer in all age group probably due to viral infection..^{[1] [2]}

• [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Template:WH Template:WS